Although MG supplementation significantly decreased serum ALT (−17%), AST(−36%), cholesterol (−20%), triglyceride (−28%), FFA (−44%), creatinine (−33%), and BUN (−27%) levels in the HFD + STZ + MG group compared to the HFD + STZ group (p < .0001), the level of these parameters was still higher than in the control and MG groups (p < .01 for creatinine, p < .0001 for others), except BUN (p > .05). The gene discussed is GPT; the disease is myasthenia gravis.